Funder
Peking Union Medical College Hospital
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Cohen, A. J., Nikbakht, N., & Uitto, J. (2023). Keloid Disorder: Genetic Basis, Gene Expression Profiles, and Immunological Modulation of the Fibrotic Processes in the Skin. Cold Spring Harbor Perspectives in Biology, 15, a041245.
2. Gouda, M. H., Elbaathy, S. A., Abd Elkareem, A. H., & Sabry, H. H. J. B. M. J. (2021). Comparison between Dermoscopic and Histopathological Features of Keloids and Hypertrophic Scars Before and After Different Treatment Modalities., 38, 750–764.
3. Ekstein, S. F., Wyles, S. P., Moran, S. L., & Meves, A. (2021). Keloids: a review of therapeutic management. International Journal of Dermatology, 60, 661–71.
4. Elsaie ML. (2021) Update on management of keloid and hypertrophic scars: A systemic review. Journal of cosmetic dermatology.20:2729–38.
5. Ogawa, R., Dohi, T., Tosa, M., Aoki, M., & Akaishi, S. (2021). The Latest Strategy for Keloid and Hypertrophic Scar Prevention and Treatment: The Nippon Medical School (NMS) Protocol. Journal of Nippon Medical School, 88, 2–9.